2014 Fiscal Year Final Research Report
Development of a new type of anti-tuberculosis vaccines by the use of lipid immunity
| Project/Area Number |
24390255
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (B)
|
| Allocation Type | Partial Multi-year Fund |
|---|
| Section | 一般 |
|---|
| Research Field |
Infectious disease medicine
|
|---|
| Research Institution | Kyoto University |
|---|
Principal Investigator |
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
IGARASHI Tatuhiko 京都大学, ウイルス研究所, 教授 (90467431)
NAKAMURA Takashi 北海道大学, 薬学研究科(研究院), 助教 (20604458)
HARASHIMA Hideyoshi 北海道大学, 薬学研究科(研究院), 教授 (00183567)
|
|---|
| Project Period (FY) |
2012-04-01 – 2015-03-31
|
| Keywords | 結核 / ワクチン / 脂質 |
|---|
| Outline of Final Research Achievements |
As about one third of the world population is infected with Mycobacterium tuberculosis, the infectious agent that causes human tuberculosis, the development of more effective vaccines than BCG, the only anti-tuberculosis vaccine currently available worldwide, is urgently needed. This principal investigator has contributed to advances in the frontier research of immune responses against tuberculosis-associated lipids. In this project, this research group has attempted to extend the basic achievements to the development of a new type of lipid-based vaccines against human tuberculosis. Using the guinea pig model of human tuberculosis, this group was successful in establishing a prototypic lipid vaccine. Furthermore, a new protocol capable of efficiently eliciting lipid-specific immune responses has been established for non-human primates, such as rhesus monkeys. These contributions provide the basis for the future development of anti-tuberculosis vaccines against human tuberculosis.
|
| Free Research Field |
感染症内科学
|
